Fosun International Limited (FOSUF) Fair Value & Analysis
Industrials · US · Market cap $3.5B
Fair value as of: Jun 26, 2026
Analysis
Fosun International Limited (FOSUF) currently trades at $0.4300, while our model-based Fair Value estimate is $0.0800 — implying the stock looks roughly 81.4% overvalued today. We read business quality at 80/100 (high quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).
About the company
Fosun International Limited operates in the health, happiness, wealth, and intelligent manufacturing sectors in Mainland China, Portugal, and internationally. It operates through five segments: Health, Happiness, Insurance, Asset Management, and Intelligent Manufacturing. The Health segment engages in the research, development, manufacture, sale, and trading of pharmaceutical and health products; and provision of medical and health management services. The Happiness segment operates and invests in tourism and leisure, fashion consumer, and lifestyle industries. The Insurance segment operates and invests in the insurance business. The Asset Management segment engages in the operation and investment of asset management, market investments, and investments in other companies of the Group. The Intelligent Manufacturing segment operates and invests in the intelligent manufacturing business; and produces iron, steel, new functional material, and ore. It is also involved in the capital inv…
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Fosun International Limited (FOSUF) undervalued?
What is the fair value of FOSUF?
What is the quality score of FOSUF?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.